Human T, Cygenia, etc.

＜2160＞Preparing to apply for a market classification change to the GNI Tokyo Stock Exchange Prime Market signed a business alliance (strategic partnership agreement) with Governance Partners, which handles the recruitment and management of investment funds Ortz, which handles P.A.I. (personal artificial intelligence) research and development, etc., established a joint venture with Governance Partners ＜3691＞Digital Plus earnings forecast revised, operating profit forecast 0.25 billion yen ←△ 102 million yen ＜4068＞Basis Downward revisions, current operating profit

Fisco JapanMay 15 18:30 ET

Carna Biosciences: Extraordinary Report

EDINETMay 15 03:51 ET · Announcements

Carna Biosciences: Confirmation

EDINETMay 12 20:38 ET · Announcements

Carna Biosciences: Quarterly Report - 22nd Term 1st Quarter (2024/01/01 - 2024/03/31)

EDINETMay 12 20:37 ET · Announcements

Carna Biosciences 1Q Loss Y398.00M Vs Loss Y519.00M

Carna Biosciences Inc. (4572.TO) Japan 1st Quarter Ended March 31 GROUP 2024 2023 Revenue Y180.00 mln Y226.00 mln Operating Profit (Y416

Dow JonesMay 10 02:32 ET

Carna Biosciences: Financial results presentation for the 1st quarter of the fiscal year ending 2024/12

JPXMay 10 02:30 ET · Announcements